Introduction
Lung cancer maintains a serious common reason of tumor-related deaths in developed nations [
1]. About 78% of lung cancers belong to the category of non-small cell lung cancer (NSCLC). Further, NSCLC is pathologically divided into four groups: adenocarcinoma, squamous cell carcinoma (SCC), large cell carcinoma and neuroendocrine cancer [
2]. Targeted molecular treatments have offered a number of appealing benefits to patients with adenocarcinoma [
3‐
5]. However, these new therapies have brought not much effect in lung squamous cell carcinoma (LUSC) [
6]. Thence, we need more valid treatments based on genomic methods for LUSC.
Plenty of studies have revealed that long noncoding RNAs (lncRNAs) may serve as crucial cis- or trans-regulators in multiple biological behaviors [
2,
7]. Mutation and modulation of lncRNA expression will influence a large number of diseases. MicroRNA-205 host gene (MIR205HG) has been proofed to accelerate cell growth in Head and Neck Squamous Cell Carcinoma (HNSCC) by down-regulating miR-590-3p [
8]. Nevertheless, studies on the function of MIR205HG in the progression of LUSC are still blank, so its biological functions are needed to be featured.
Recently, according to findings on a wide range of non-coding RNAs, microRNAs (miRNAs) are small non-coding RNAs participating in the suppression or down-regulation of target gene transcription in the way of sequence-dependent [
1,
2]. The capacity of miRNAs is particular. A miRNA can control a great deal of protein-coding RNAs of human cells [
9,
10]. Thence, regulating RNA networks may be interfered by the aberrant expression of miRNAs [
11,
12], which is conducive to tumorigenesis, tumor metastasis and drug resistance [
3,
4]. As a matter of fact, aberrantly expressed miRNAs have been studied in different cancers, including lung SCC [
5,
13]. For instance, the expression levels of miR-133a were shown dramatically low in prostate cancer tissues compared with adjacent normal tissues [
14]. MiR-299-3p has been explored to express aberrantly in certain types of cancers, such as colon carcinoma and lung cancer [
15‐
17]. The exact role and functional mechanism of miR-299-3p in LUSC maintain uncovered. Thence, this study was designed to explore the molecular mechanism of relationship between MIR205HG and miR-299-3p in LUSC.
Methods
Cell culture
Human normal lung epithelial cell (BEAS-2B) and lung cancer cells (NCI-H520, SK-MES-1, NCI-H1703) were all bought from Chinese Academy of Sciences (Beijing, China). The above cells were inoculated in RPMI-1640 medium (Invitrogen, Carlsbad, CA, USA) adding 10% FBS (Invitrogen), then mixed with 1% penicillin/streptomycin (Sigma-Aldrich, Milan, Italy) and cultivated in a 5% CO2 incubator at 37 °C. medium for incubation was required to change every 3 days.
Cell transfection
Cells were put into a fresh 6-well plate until cells were passaged at 80% confluence. NCI-H520 and SK-MES-1 cells were co-transfected with shRNAs targeting MIR205HG (sh-MIR205HG#1/#2) and sh-NC. The pcDNA3.1/MIR205HG, pcDNA3.1/MAP 3 K2 and the empty pcDNA3.1 were constructed by Genechem (Shanghai China). The miR-299-3p mimics and NC-mimics were also gained from Genechem. All transfections were conducted by Lipofectamine 2000 (Invitrogen).
Quantitative real-time polymerase chain reaction (qRT-PCR) analysis
Total RNAs of cells were extracted by TRIzol reagent which was purchased from Invitrogen. The total RNAs were reverse-transcribed into cDNA under a Reverse Transcription Kit (Invitrogen). qRT-PCR analysis was achieved using SYBR Green Premix PCR Master Mix (Roche, Mannheim, Germany) under ABI HT9600 (Applied Biosystems, Foster City, CA, USA). The fold expression changes were calculated by using 2-∆∆Ct method, and GAPDH/U6 was seen as the endogenous control.
SK-MES-1 and NCI-H520 cells were plated into 6-well plates and cultured after transfection. After 14 days, cells were cleaned with PBS (Sigma-Aldrich) and fixed in paraformaldehyde (Sigma-Aldrich) for 10 min, dyed by crystal violet (Sigma-Aldrich) for 5 min. Finally, the visible colony numbers were calculated manually.
Transwell migration assay
Serum-free medium containing SK-MES-1 and NCI-H520 cells was placed in the top compartment and the lower compartment was filled with 10% FBS (Sigma-Aldrich). Matrigel (Corning Incorporated, NY, USA) was additionally pre-coated on the apical compartment for migration assay. After cultivating for 48 h, the bottom of the chamber was fixed by methanol (Sigma-Aldrich), and then dyed with crystal violet (Sigma-Aldrich). The cells that had migrated were counted at 5 randomly chosen visual fields using an inverted microscope (Olympus, Tokyo, Japan).
Western blot analysis
When reached to 80–90% confluent, cells were collected for total protein extraction by using RIPA cell lysis. After the concentration measured via a Pierce Bicinchoninic acid (BCA) Protein detection kit (Bio-Rad Laboratories, Hercules, CA, USA), proteins were isolated by performing SDS-PAGE and then moved onto a PVDF membrane (Beyotime, Shanghai, China). The membrane was sealed with 5% fat-free milk and rinsed by Tris-buffered saline/Tween 20 (TBST), followed by overnight incubation with the primary antibodies at 4 °C. The primary antibodies used in this study were as below: anti-E-cadherin (ab194982, Abcam), anti-N-cadherin (ab202030, Abcam), anti-Vimentin (ab193555, Abcam), anti-MAP 3 K2 (ab33918, Abcam) and antiGAPDH (ab8245, Abcam). Following washing in TBST, the membranes were subjected to 2 h of incubation with secondary antibodies at room temperature. The, the blots were visualized by the application of enhanced chemiluminescence (ECL; Amersham Pharmacia Biotec, Buckinghamshire, UK). GAPDH served as the internal control. The experiment was conducted in triplicate.
Apoptosis analysis
Cell apoptosis was examined at 48 h after transfection using FITC Annexin V/PI Apoptosis Detection Kit I (Ribobio, Guangzhou, China). In short, cells were reaped and cleaned in PBS (Sigma-Aldrich) and resuspended in 70% cooled ethanol (Sigma-Aldrich). The apoptosis ratio was determined by using FlowJo software (Ashland, OR, USA).
RNA immunoprecipitation (RIP) assay
RIP experiments were performed using the Magna RNA-Binding Protein Immunoprecipitation Kit (Millipore, MA, USA). Then, cell lysates were cultivated with RIP buffer containing magnetic beads conjugated with human anti-Ago2 (ab32381, Abcam) or anti-IgG (Millipore, MA, USA). Furthermore, qRT-PCR was performed to evaluate the expression levels of MIR205HG, miR-299-3p and MAP 3 K2. Normal IgG was considered as control.
Luciferase reporter assay
The wild-type and mutant binding sites of MIR205HG or MAP 3 K2 to miR-209-3p were sub-cloned into pmirGLO dual-luciferase vector to construct plasmids and then co-transfected with miR-299-3p mimics and pcDNA3.1/MIR205HG into NCI-H520 or SK-MES-1 cells, separately. Dual-luciferase reporter system was applied for detecting the activity of luciferase.
Statistical analysis
Data analysis was performed using GraphPad Prism 7 software package (La Jolla, CA, USA). Data came from at least three independent assays were showed as mean ± standard deviation (SD). ANOVA analysis and Student’s t-test were employed for evaluating difference of 2 or more groups. P < 0.05 had statistical significance.
Discussion
This study indicated that MIR205HG may be a crucial regulator for cell proliferation, migration and EMT progression in LUSC. First of all, we found that the expressions of MIR205HG in LUSC tissues and cell lines (NCI-H520, SK-MES-1 and NCI-H1703) were highly expressed. In addition, down-regulation of MIR205HG suppressed cell proliferation, migration and EMT process, whereas enhanced cell apoptosis. Besides, the results also revealed that reducing MIR205HG increased the expression level of miR-299-3p. It further proved that MIR205HG was an upstream factor for miR-299-3p. On the other hand, MAP 3 K2 acted as the target gene of miR-299-3p, which was regulated by MIR205HG indirectly. Increasing MAP 3 K2 expression could restore the effects caused by inhibiting MIR205HG on cell biological functions. To sum up, MIR205HG could regulate MAP 3 K2 expression via miR-299-3p to promote the progression of LUSC. Furthermore, evidence of MIR205HG functionality in LUSC might extend to clinical pathologic features of LUSC patients. This study may have some referential meaning for the development of possible therapeutics against LUSC.
It is well-acknowledged that lncRNAs have multiple molecular functions, including adjusting transcriptional forms and protein activities and altering RNA processes [
20,
21]. However, it is still not clear whether these lncRNAs are the causes or symptoms of morbid state. A vast number of studies have indicated that many disordered lncRNAs existed in all types of human diseases, including cancers [
22,
23]. This research demonstrated the high expression of MIR205HG in LUSC tissues and cell lines. Depletion of MIR205HG repressed cellular activities in LUSC, suggesting that MIR205HG worked as an oncogene in LUSC.
Generally, miRNAs play a role in cancer cells by means of promoting degradation of the targeted genes [
24,
25]. ABCE1 is the target gene of miR-299-3p in lung cancer cells [
16]. In human colon carcinoma, miR-299-3p suppresses the tumor process in the way of immediately targeting VEGFA [
15]. Then we intended to probe a new target of miR-299-3p in LUSC cells. In this study, MAP 3 K2 was identified as the target mRNA of miR-299-3p. Overexpressing MIR205HG could cut down miR-299-3p expression through binding with it. In the same time, MIR205HG enhanced MAP 3 K2 expression via sequestering miR-299-3p.
Previous papers found out that MAP 3 K2 could distinguish tumor cells from non-tumor normal cells [
18]. Furthermore, MAP 3 K2 contributes to the growth and migration of liver cancer cells [
24,
25]. MiR-520b targeting MAP 3 K2 could impair hepatoma cell proliferation ability [
19]. These findings all revealed that MAP 3 K2 probably play a significant role in the development of liver cancer. Similarly, MAP 3 K2 in this research was proved to exert tumor-promoting effects in LUSC. In rescue function assays, up-regulating MAP 3 K2 expression recovered cell proliferation and migration abilities and EMT process, which were impaired by depleting MIR205HG.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit
http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (
http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.